|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,395.00 TWD | 0.00% |
|
+20.78% | +196.81% |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 06-11 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 16.22B | |||||
| 59.1B | |||||
| 55.19B | |||||
| 24.67B | - | ||||
| 24.19B | - | ||||
| 19.69B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
